NCT05973864
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05973864
Title Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery (CAPPA)
Acronym CAPPA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Amiens Picardie_Site Sud RECRUITING Amiens 80054 France Details
Institut Sainte Catherine RECRUITING Avignon 84918 France Details
Centre Hospitalier de la Côte Basque RECRUITING Bayonne 64109 France Details
CHU Jean Minoz RECRUITING Besançon France Details
Polyclinique Bordeaux Nord Aquitaine RECRUITING Bordeaux 33077 France Details
Centre François Baclesse RECRUITING Caen 14000 France Details
Centre Georges-François Leclerc RECRUITING Dijon France Details
CHD Vendee RECRUITING La Roche-sur-Yon France Details
Centre Oscar Lambret RECRUITING Lille France Details
Centre Léon Bérard RECRUITING Lyon 69008 France Details
Institut Paoli-Calmettes RECRUITING Marseille 13009 France Details
Institut Curie RECRUITING Paris 75005 France Details
Clinique de La Croix du sud RECRUITING Quint-Fonsegrives 31130 France Details
Institut Godinot RECRUITING Reims 51100 France Details
Institut Curie RECRUITING Saint-Cloud 92210 France Details
Clinique Mutualiste de l'Estuaire RECRUITING Saint-Nazaire France Details
Centre Paul Strauss RECRUITING Strasbourg France Details
Institut Claudius Regaud, IUCT Oncopole RECRUITING Toulouse France Details
CHU Bretonneau RECRUITING Tours 37000 France Details
Institut de Cancérologie de Lorraine RECRUITING Vandœuvre-lès-Nancy 54519 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field